Acute onset convulsive disorders in the canine may result from exposure to a variety of toxicants including strychnine, insecticides, metaldehyde, zinc phosphide, methylxanthines, drugs of abuse, bromethalin, and the tremorgenic mycotoxins (roquefortine and penitrem A). Although several of the above can be identified in a single gas chromatography-mass spectrometry (GC-MS) screen most have to be determined by separate tests. This report describes a modification of the strychnine extraction procedure, which allows thin layer chromatographic (TLC) identification of strychnine, bromethalin, roquefortine, and penitrem A in suspect baits, stomach contents or vomitus, and extends the identification to a wide variety of drugs, pesticides, and environmental contaminants by GC-MS. Samples were mixed with base, extracted into CH 2 Cl 2 and the organic fraction back-extracted with acid. The organic fraction (neutrals) was purified by gel permeation chromatography (GPC) and analyzed by TLC to determine penitrem A and bromethalin. The acidic aqueous fraction was adjusted to pH Ͼ 9 and extracted into CH 2 Cl 2 . The resulting CH 2 Cl 2 layer (bases) was then analyzed by TLC to determine strychnine and roquefortine. The organic basic and neutral fractions were recombined with a late eluting GPC fraction and analyzed by GC-MS. Of 312 samples analyzed by TLC from 1995 to 2001, 35 were positive for strychnine alone, 58 were positive for both roquefortine and penitrem A, 4 were positive for roquefortine alone, and 1 was positive for bromethalin. None of the samples were positive for penitrem A alone. Samples negative by TLC were analyzed by the GC-MS extended procedure since mid-1999, and 14 have shown positive for a wide variety of compounds with convulsant activity.
Acute onset convulsive disorders in the canine may result from exposure to a variety of toxicants including strychnine, insecticides, metaldehyde, zinc phosphide, methylxanthines, bromethalin, and the tremorgenic mycotoxins (roquefortine and penitrem A), as well as some human drugs of abuse. 3, 4 Several of the above (insecticides, metaldehyde, and drugs of abuse) can be identified in a single gas chromatography-mass spectrometry (GC-MS) screen, 1 but most have to be determined by individual tests. To identify additional suspect toxicants in strychnine negative samples, an extraction procedure for neutral compounds as well as alkaloids was developed. 3 This method allowed thinlayer chromatographic (TLC) identification of the tremorgenic mycotoxins (roquefortine and penitrem A) and the rodenticides (bromethalin and strychnine) in suspect baits, stomach contents, or vomitus. 2 The procedure has now been further extended by GC-MS to allow identification of additional central nervous system (CNS) active compounds including drugs, organochlorine, organophosphate (and certain carbamate) insecticides, and metaldehyde.
Ten vomitus were mixed with 10 ml H 2 O (18 meg-ohm, organic free from a 4 bowl Milli-Q System), a 5 ml of 1 N NaOH and 0.1 ml diphenylamine b (100 g/ml in MeOH) in a 250 ml separatory funnel, and allowed to stand for 5 minutes. The mixture was extracted into 100 ml CH 2 Cl 2 (all organic solvents were UV grade c ), filtered through anhydrous Na 2 SO 4 into a 100 ml graduated cylinder with stopper, and the volume of recovery recorded. Then 10 ml of 0.1 N H 2 SO 4 was added to the CH 2 Cl 2 and the organic fraction back-extracted by inverting the graduate 10-12 times, carefully releasing the pressure. The organic fraction was separated and passed through anhydrous Na 2 SO 4 into a 250 ml round bottom flask and taken to dryness under vacuum on a rotary evaporator. It was taken up in 4 ml cyclohexane-CH 2 Cl 2 (1:1) and purified by gel permeation chromatography (GPC) on a 2.5 ϫ 18 cm column of Biobeads S-X3 d (20 g) in cyclohexane-CH 2 Cl 2 (1:1) at 5 ml/minute. An early eluting fraction (125-200 ml) was dried and analyzed by TLC to determine the neutrals, penitrem A e and bromethalin (a generous gift from Lilly Research Laboratories), while a following (200-455 ml) late eluting fraction (late GPC fraction) was collected for GC-MS analysis (see below). The acidic aqueous fraction was adjusted to pH Ͼ 9 by adding 2 ml 1 N NaOH and extracted into 12 ml CH 2 Cl 2 in a 50 ml conical tube with stopper. The re- sulting CH 2 Cl 2 layer (bases) was removed from the bottom, drained through anhydrous Na 2 SO 4 , concentrated under a stream of N 2 and analyzed by TLC to determine strychnine b and roquefortine. e TLC for neutrals was developed in cyclohexaneethyl acetate-acetic acid (78:20:2) with visualization by UV quenching on fluorescent plates f followed by methanol-H 2 SO 4 (1:1) spray and charring at 100 C. Confirmation of neutrals was by GC-MS (bromethalin) or MS-MS (penitrem A). 3 TLC for bases was developed in ethyl acetate-methanol-NH 4 OH (85:10:5) with visualization by UV quenching on the fluorescent plates. This was followed by methanol-H 2 SO 4 (1:1) spray and charring at 100 C if roquefortine was tentatively identified by UV quenching, or by iodoplatinate spray if strychnine was tentatively identified. Confirmation of bases was by TLC in methanol-1.5% NH 4 OH with visualization by UV absorbance followed by methanol-H 2 SO 4 (1:1) spray and charring at 100 C. Samples fortified with 1 ppm of strychnine and 10 ppm of penitrem A, roquefortine, and bromethalin were analyzed for qualitative recovery with each group of unknowns as a quality control measure.
If the TLC screen mentioned above for neutrals and bases was negative, the remaining neutral and base fractions were combined with the late GPC fraction, and analyzed by GC-MS ( Fig. 1) . Qualitative GC-MS was carried out on the mass selective detector (MSD) as described previously. 1 The equipment used for 70 eV electron-impact (EI) mass spectrometry consisted of an autosampler interfaced to a GC and MSD. g The GC column was a 30 m ϫ 0.25 mm ID ϫ 0.25 m (film) DB-5MS. h The column was temperature programmed from 80 to 300 C, and 70 eV EI spectra were collected at m/z 40-700. As a control check on the qualitative recovery of drugs and pesticides through the extraction and clean-up procedures, samples of stomach contents, vomitus, or suspect baits were fortified with a mixture containing approximately 5 ppm each of methamidophos, i carbaryl, i malathion, i aldrin, i dieldrin, i and the internal standard, diphenylamine. Qualitative recoveries were checked by comparison of the GC retention time and mass spectrum of each individual compound with that in the unspiked standard mixture analyzed under the same conditions. Unknown spectra found in suspect cases were searched against a mass spectral library, j which contained additional compounds added ''in house.'' Tentative positives were confirmed by compar-ison of GC retention times and mass spectra to those of authentic reference standards. Table 1 shows the TLC R f values for the neutral and basic compounds in the primary and confirmatory TLC solvent systems. Also shown are the colors of the spots before and after viewing by the several spray reagents used. This aided in the confirmation of the compounds. From 1995 through 2001, 312 samples from cases involving convulsive disorders in dogs were submitted to the laboratory with the request for a convulsant screen. They were analyzed for strychnine, penitrem A, roquefortine, and bromethalin by the TLC procedure. Of those, 35 were positive for strychnine alone, 58 were positive for both penitrem A and roquefortine, and 4 for roquefortine alone. None of the samples were positive for penitrem A alone (Fig. 2) , whereas one sample was positive for bromethalin (in 2001).
Since mid-1999, samples negative by the TLC screen have been analyzed by GC-MS. Samples spiked with a mixture containing approximately 5 ppm each of methamidophos, carbaryl, malathion, aldrin, dieldrin, and the internal standard, diphenylamine were analyzed concurrently with the unknowns. These compounds, including organophosphate, carbamate, and organochlorine insecticides, were used to assess the potential recovery of like compounds through the entire extraction, cleanup, and GC-MS determinative process. Some were chosen to test particularly sensitive aspects of the procedure. Methamidophos and carbaryl, for instance, are sensitive to the condition of the GC injector port and active site formation on the capillary column, shown by increased peak tailing of methamidophos and breakdown of carbaryl to 1-naphthalenol. The semivolatile diphenylamine is lost if care is not taken with the solvent reduction steps. Dieldrin elutes from the GPC a little before the other insecticides and with some overlap with cholesterol. It is used to confirm that the collection volume of the GPC column remains within the expected range. Malathion and aldrin are least affected by chromatographic conditions and provide confidence in the overall extraction procedure.
The addition of the GC-MS examination has turned up a surprising variety of compounds with known convulsant activity (Table 2) including metaldehyde, or-ganochlorine, organophosphate and carbamate pesticides, and various drugs. Of the 103 cases in 2000-2001 that were negative for the convulsants, 14 were found to be positive by the GC-MS extension. The GC-MS extension detected the methylxanthine caffeine but not theobromine and theophylline, which appeared to be lost on the GPC column. Additional support for the wide-range capability of the GC-MS extension to identify drugs of various types comes with the routine identification of anticonvulsants and sedatives used in treatment, such as diazepam, nordiazepam, ketamine, and xylazine.
The findings above clearly confirm earlier findings that in cases of convulsive disorders or with other CNS disturbances, negative strychnine screens need to be followed up thoroughly by examination for tremorgenic mycotoxins. 4 Furthermore, the findings here indicate that where all are negative, GC-MS for pesticides and drugs is necessary. The method described here allows for the GC-MS determination of a wide variety of CNS-active compounds in fractions obtained during the extraction and purification of samples for the determination of alkaloids and tremorgenic mycotoxins. This can be achieved without the need for additional processing, an especially significant advantage in cases where a limited amount of suspect sample is available to the laboratory. Clearly, with sufficient time and sample, a full GC-MS screen may allow determination of some compounds sensitive to the strong alkali used in the initial alkaloid extraction procedure. In addition, procedures for specific classes of com-pounds not amenable to the GC-MS screen, such as theobromine and theophylline, may need to be conducted.
